Prescription drug · NDA
Vimpat (Lacosamide) NDC 0131-2478
Lacosamide 100 mg/1 · Tablet, Film coated · Oral · UCB, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0131-2478-35 | 0013124783500131247835 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0131-2478-35)Marketed from May 26, 2009 | |
| 0131-2478-60 | 0013124786000131247860 | 6 BLISTER PACK in 1 CARTON (0131-2478-60) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from May 26, 2009 | |
| 0131-2478-99 | 0013124789900131247899 | 1 BLISTER PACK in 1 CARTON (0131-2478-99) / 14 TABLET, FILM COATED in 1 BLISTER PACKMarketed from May 26, 2009 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Vimpat
- Generic name (nonproprietary)
- lacosamide
- Active ingredients
- Lacosamide — 100 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- UCB, Inc.NDC labeler code 0131
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022253
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 0131-2478_51a12988-3e4b-c52b-e063-6394a90a7415SPL ID 51a12988-3e4b-c52b-e063-6394a90a7415SPL set ID 9e79b42c-38a3-4b2c-a196-a5a1948250e2RxCUI 809974, 809984, 809987, 809990, 809992, 809994, 809996, 809998, 810000, 810002, 993856, 995156UNII 563KS2PQY5
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400131247835followed by a unit qualifier and the quantityPackage 00131-2478-35. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
VIMPAT is indicated for: Treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 ) 1.1 Partial-Onset Seizures VIMPAT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures VIMPAT is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.
Excerpt only. Read the full label for complete information.
About NDC 0131-2478
- What is NDC 0131-2478?
- 0131-2478 is the product NDC for Vimpat (lacosamide), Lacosamide 100 mg/1 tablet, film coated, listed with the FDA by UCB, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Vimpat (Lacosamide).
- What is the active ingredient?
- Lacosamide.
- Who is the labeler?
- UCB, Inc., NDC labeler code 0131. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Vimpat?
- 5 other product NDCs are listed under this name. See all Vimpat NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Vimpat products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Vimpatlacosamide | Lacosamide 10 mg/mL | SolutionOral | UCB, Inc. | 0131-5410 | 00131-5410-72 |
| Vimpatlacosamide | Lacosamide 10 mg/mL | InjectionIntravenous | UCB, Inc. | 0131-1810 | 00131-1810-67 |
| Vimpatlacosamide | Lacosamide 50 mg/1 | Tablet, Film coatedOral | UCB, Inc. | 0131-2477 | 00131-2477-3500131-2477-6000131-2477-99 |
| Vimpatlacosamide | Lacosamide 150 mg/1 | Tablet, Film coatedOral | UCB, Inc. | 0131-2479 | 00131-2479-3500131-2479-6000131-2479-99 |
| Vimpatlacosamide | Lacosamide 200 mg/1 | Tablet, Film coatedOral | UCB, Inc. | 0131-2480 | 00131-2480-3500131-2480-6000131-2480-99 |
Other NDCs under NDA 022253
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Vimpatlacosamide | Lacosamide 50 mg/1 | Tablet, Film coatedOral | UCB, Inc. | 0131-2477 |
| Vimpatlacosamide | Lacosamide 150 mg/1 | Tablet, Film coatedOral | UCB, Inc. | 0131-2479 |
| Vimpatlacosamide | Lacosamide 200 mg/1 | Tablet, Film coatedOral | UCB, Inc. | 0131-2480 |